ERBB2 and carcinoma: Overexpression of HER2 due to gene amplification leads to cell proliferation, inhibition of apoptosis, and angiogenesis, which are major factors contributing to aggressive carcinoma (Hansel et al., 2008; Fleischmann et al., 2011).